Impact of fenfluramine on the expected SUDEP mortality rates in patients with Dravet syndrome-Reference-Cited by-同舟云学术

Impact of fenfluramine on the expected SUDEP mortality rates in patients with Dravet syndrome

Published:2021-12 Issue: Volume:93 Page:154-159
ISSN:1059-1311
Container-title:Seizure
language:en
Short-container-title:Seizure

Author:

Cross J. Helen,Galer Bradley S.,Gil-Nagel Antonio,Devinsky Orrin,Ceulemans Berten,Lagae Lieven,Schoonjans An-Sofie,Donner Elizabeth,Wirrell Elaine,Kothare Sanjeev,Agarwal Anupam,Lock Michael,Gammaitoni Arnold R.

Funder

Zogenix Inc

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,General Medicine

Reference41 articles.

1. The core Dravet syndrome phenotype;Dravet;Epilepsia,2011

2. Quality of life and comorbidities associated with Dravet syndrome severity: a multinational cohort survey;Lagae;Dev Med Child Neurol,2018

3. Dravet syndrome: characteristics, comorbidities, and caregiver concerns;Villas;Epilepsy Behav,2017

4. The incidence of SCN1A-related Dravet syndrome in Denmark is 1:22,000: a population-based study from 2004 to 2009;Bayat;Epilepsia,2015

5. Aberrant inclusion of a poison exon causes Dravet syndrome and related SCN1A-associated genetic epilepsies;Carvill;Am J Hum Genet,2018

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fenfluramine treatment in pediatric patients with Dravet syndrome reduces seizure burden and overall healthcare costs: A retrospective and observational real‐world study;Epilepsia Open;2024-08-14

2. Practical considerations for the use of fenfluramine to manage patients with Dravet syndrome or Lennox–Gastaut syndrome in clinical practice;Epilepsia Open;2024-07-04

3. Comprehensive scoping review of fenfluramine's role in managing generalized tonic–clonic seizures in developmental and epileptic encephalopathies;Epilepsia;2024-06-21

4. Cost Effectiveness of Adding Fenfluramine to Standard of Care for Patients with Dravet Syndrome in Sweden;Applied Health Economics and Health Policy;2024-05-17

5. Prevention of Drug Resistant Epilepsy and Developmental Epileptic Encephalopathy: Preventative Vigabatrin Treatment in Tuberous Sclerosis Complex and the Case for Fenfluramine Treatment of Children with Newly Diagnosed Dravet Syndrome;OBM Genetics;2024-05-08